Norma Guzmán‐Becerra
About
Norma Guzmán‐Becerra is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics.
According to data from OpenAlex, Norma Guzmán‐Becerra has authored 20 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pathology and Forensic Medicine and 6 papers in Genetics. Recurrent topics in Norma Guzmán‐Becerra's work include Viral-associated cancers and disorders (9 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Norma Guzmán‐Becerra is often cited by papers focused on Viral-associated cancers and disorders (9 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Norma Guzmán‐Becerra collaborates with scholars based in United States, France and United Kingdom. Norma Guzmán‐Becerra's co-authors include Bruce M. Ewenstein, Wing-Yen Wong, J. Phillips, Sandra Vallin Antunes, Srilatha Tangada, James R. Freed, Marvin Marcus, Oleksandra Stasyshyn, Vasily Mamonov and Ricky N. Bluthenthal and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal of Public Health.
In The Last Decade
Norma Guzmán‐Becerra
20 papers receiving 318 citations
Peers
Norma Guzmán‐Becerra
Romulo Vianna Brazil
Evgenios Koumantakis Greece
Friederike Mumm Germany
Apichati Sivayathorn Thailand
Gemma Dyer Australia
AE Grulich Australia
Qianxi Feng United States
Ranjit Thomas United Kingdom
Simone Martins de Castro Brazil
Henrik Hjalgrim Denmark
Citations per year, relative to Norma Guzmán‐Becerra Norma Guzmán‐Becerra (= 1×)
peers
Romulo Vianna
Countries citing papers authored by Norma Guzmán‐Becerra
Since
Specialization
Citations
This map shows the geographic impact of Norma Guzmán‐Becerra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norma Guzmán‐Becerra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norma Guzmán‐Becerra more than expected).
Fields of papers citing papers by Norma Guzmán‐Becerra
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Norma Guzmán‐Becerra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norma Guzmán‐Becerra. The network helps show where Norma Guzmán‐Becerra may publish in the future.
Co-authorship network of co-authors of Norma Guzmán‐Becerra
This figure shows the co-authorship network connecting the top 25 collaborators of Norma Guzmán‐Becerra. A scholar is included among the top collaborators of Norma Guzmán‐Becerra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norma Guzmán‐Becerra. Norma Guzmán‐Becerra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Barlev, Arie, et al.. (2024). Comparative analysis of tabelecleucel and current treatment in patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease following hematopoietic cell transplant or solid organ transplant. Journal of Medical Economics. 27(1). 789–795.
2.
Mahadeo, Kris M., Robert A. Baiocchi, Amer Beitinjaneh, et al.. (2024). Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial. The Lancet Oncology. 25(3). 376–387.
3.
Socié, Gèrard, Pere Barba, Arie Barlev, et al.. (2023). Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy. Bone Marrow Transplantation. 59(1). 52–58.
4.
Mahadeo, Kris M., Robert A. Baiocchi, Amer Beitinjaneh, et al.. (2022). New and Updated Results from a Multicenter, Open-Label, Global Phase 3 Study of Tabelecleucel (Tab-cel) for Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) Following Allogeneic Hematopoietic Cell (HCT) or Solid Organ Transplant (SOT) after Failure of Rituximab or Rituximab and Chemotherapy (ALLELE). Blood. 140(Supplement 1). 10374–10376.
5.
Sanz, Jaime, Jan Storek, Gèrard Socié, et al.. (2021). Clinical Outcomes of Patients with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Hematopoietic Stem Cell Transplantation Who Fail Rituximab: A Multinational, Retrospective Chart Review Study. Blood. 138(Supplement 1). 1454–1454.
6.
Torno, Lilibeth, Ann Dahlberg, Armin Ghobadi, et al.. (2020). Clinical Experience of Tabelecleucel in Patients with Life-Threatening Complications of Epstein-Barr Virus Viremia. Blood. 136(Supplement 1). 7–8.
7.
Aftab, Blake T., Rhine R. Shen, Norma Guzmán‐Becerra, et al.. (2020). Correlation of Epstein-Barr virus-specific cytotoxic T lymphocyte precursors (EBV-CTLp) after tabelecleucel with response and survival in rituximab relapsing or refractory EBV+ post-transplant lymphoproliferative disease (PTLD).. Journal of Clinical Oncology. 38(5_suppl). 38–38.
8.
Nikiforow, Sarah, Robert A. Baiocchi, Sunita D. Nasta, et al.. (2020). 1051P Clinical experience of tabelecleucel in patients with EBV+ primary (PID) or acquired immunodeficiency (AID) associated lymphoproliferative disease. Annals of Oncology. 31. S719–S719.
9.
Prockop, Susan E., Rajani Dinavahi, Willis H. Navarro, et al.. (2020). A Multicenter, Multicohort, Open-Label, Single-Arm per Cohort, Phase II Study to Assess the Efficacy and Safety of Tabelecleucel in Patients with EBV-Associated Diseases Using an Adaptive Two-Stage Study Design. Blood. 136(Supplement 1). 4–5.
10.
Valentino, Leonard A., et al.. (2014). ADVATE prophylaxis: post hoc analysis of joint bleeding episodes. Haemophilia. 20(5). 630–638.
11.
Antunes, Sandra Vallin, Srilatha Tangada, Oleksandra Stasyshyn, et al.. (2013). Randomized comparison of prophylaxis and on‐demand regimens with FEIBA NF in the treatment of haemophilia A and B with inhibitors. Haemophilia. 20(1). 65–72.
12.
Auerswald, G., Alexis A. Thompson, Michael Recht, et al.. (2012). Experience of Advate rAHF-PFM in previously untreated patients and minimally treated patients with haemophilia A. Thrombosis and Haemostasis. 107(6). 1072–1082.
13.
Spotts, Gerald, Brigitt E. Abbuehl, Norma Guzmán‐Becerra, et al.. (2010). Safety and Efficacy Profile of rAHF-PFM for Immune Tolerance Induction as Assessed In 3 Clinical Trials (PUP ITI, PRE-PAIR, and PAIR).. Blood. 116(21). 3670–3670.
14.
Bluthenthal, Ricky N., et al.. (2005). Characteristics of Malt Liquor Beer Drinkers in a Low‐Income, Racial Minority Community Sample. Alcoholism Clinical and Experimental Research. 29(3). 402–409.
15.
Marcus, Marvin, Carl A. Maida, James R. Freed, et al.. (2005). Oral white patches in a national sample of medical HIV patients in the era of HAART. Community Dentistry And Oral Epidemiology. 33(2). 99–106.
16.
Marcus, Marvin, Carl A. Maida, Ian D. Coulter, et al.. (2005). A Longitudinal Analysis of Unmet Need for Oral Treatment in a National Sample of Medical HIV Patients. American Journal of Public Health. 95(1). 73–75.
17.
Coulter, Ian D., Marvin Marcus, James R. Freed, et al.. (2004). Self-reported oral health of enrollees in capitated and fee-for-service dental benefit plans. The Journal of the American Dental Association. 135(11). 1606–1615.
18.
Coulter, Ian D., James R. Freed, Marvin Marcus, et al.. (2004). Self-reported satisfaction of enrollees in capitated and fee-for-service dental benefit plans. The Journal of the American Dental Association. 135(10). 1458–1466.
19.
Coulter, Ian D., Kevin C. Heslin, Marvin Marcus, et al.. (2002). Associations of self-reported oral health with physical and mental health in a nationally representative sample of HIV persons receiving medical care. Quality of Life Research. 11(1). 57–70.
20.
Coulter, Ian D., Marvin Marcus, James R. Freed, et al.. (2001). Self-Reported Behavior and Attitudes of Enrollees in Capitated and Fee-for-Service Dental Benefit Plans. RAND Corporation eBooks.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Romulo Vianna Breakdown of academic impact, for papers by Evgenios Koumantakis Breakdown of academic impact, for papers by Friederike Mumm Breakdown of academic impact, for papers by Apichati Sivayathorn Breakdown of academic impact, for papers by Gemma Dyer Breakdown of academic impact, for papers by AE Grulich Breakdown of academic impact, for papers by Qianxi Feng Breakdown of academic impact, for papers by Ranjit Thomas Breakdown of academic impact, for papers by Simone Martins de Castro Breakdown of academic impact, for papers by Henrik Hjalgrim